261 related articles for article (PubMed ID: 32763426)
1. The Timing of Large Submacular Hemorrhage Secondary to Age-Related Macular Degeneration Relative to Anti-VEGF Therapy.
Matsunaga DR; Su D; Sioufi K; Obeid A; Wibbelsman T; Ho AC; Regillo CD
Ophthalmol Retina; 2021 Apr; 5(4):342-347. PubMed ID: 32763426
[TBL] [Abstract][Full Text] [Related]
2. Displacement of Submacular Hemorrhage Using Subretinal Cocktail Injection versus Pneumatic Displacement: A Real-World Comparative Study.
Szeto SKH; Tsang CW; Mohamed S; Lee GKY; Lok JKH; Hui VWK; Tsang KK; Chen LJ; Brelen M; Lai TYY
Ophthalmologica; 2024; 247(2):118-132. PubMed ID: 38408445
[TBL] [Abstract][Full Text] [Related]
3. The role of pigment epithelial detachment in AMD with submacular hemorrhage treated with vitrectomy and subretinal co-application of rtPA and anti-VEGF.
Treumer F; Wienand S; Purtskhvanidze K; Roider J; Hillenkamp J
Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1115-1123. PubMed ID: 28280989
[TBL] [Abstract][Full Text] [Related]
4. Management of thick submacular hemorrhage with subretinal tissue plasminogen activator and pneumatic displacement for age-related macular degeneration.
Chang W; Garg SJ; Maturi R; Hsu J; Sivalingam A; Gupta SA; Regillo CD; Ho AC
Am J Ophthalmol; 2014 Jun; 157(6):1250-7. PubMed ID: 24531021
[TBL] [Abstract][Full Text] [Related]
5. Vitrectomy, subretinal Tissue plasminogen activator and Intravitreal Gas for submacular haemorrhage secondary to Exudative Age-Related macular degeneration (TIGER): study protocol for a phase 3, pan-European, two-group, non-commercial, active-control, observer-masked, superiority, randomised controlled surgical trial.
Jackson TL; Bunce C; Desai R; Hillenkamp J; Lee CN; Lois N; Peto T; Reeves BC; Steel DH; Edwards RT; van Meurs JC; Wafa H; Wang Y
Trials; 2022 Jan; 23(1):99. PubMed ID: 35101110
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcome of subretinal coapplication of rtPA and bevacizumab followed by repeated intravitreal anti-VEGF injections for neovascular AMD with submacular haemorrhage.
Treumer F; Roider J; Hillenkamp J
Br J Ophthalmol; 2012 May; 96(5):708-13. PubMed ID: 22174095
[TBL] [Abstract][Full Text] [Related]
7. Fundus Autofluorescence Patterns in Subretinal Hemorrhages Associated with Neovascular Age-Related Macular Degeneration.
Nawrocka ZA; Nawrocki J
Ophthalmologica; 2024; 247(1):58-64. PubMed ID: 38113868
[TBL] [Abstract][Full Text] [Related]
8. Sequential tissue plasminogen activator, pneumatic displacement, and anti-VEGF treatment for submacular hemorrhage.
Bardak H; Bardak Y; Erçalık Y; Erdem B; Arslan G; Timlioglu S
Eur J Ophthalmol; 2018 May; 28(3):306-310. PubMed ID: 29148027
[TBL] [Abstract][Full Text] [Related]
9. Subretinal Coapplication of Tissue Plasminogen Activator and Bevacizumab with Concurrent Pneumatic Displacement for Submacular Hemorrhages Secondary to Neovascular Age-Related Macular Degeneration.
Avcı R; Mavi Yıldız A; Çınar E; Yılmaz S; Küçükerdönmez C; Akalp FD; Avcı E
Turk J Ophthalmol; 2021 Feb; 51(1):38-44. PubMed ID: 33631914
[TBL] [Abstract][Full Text] [Related]
10. Pneumatic Displacement of Submacular Hemorrhage with Subretinal Air and Tissue Plasminogen Activator: Initial United States Experience.
Sharma S; Kumar JB; Kim JE; Thordsen J; Dayani P; Ober M; Mahmoud TH
Ophthalmol Retina; 2018 Mar; 2(3):180-186. PubMed ID: 31047581
[TBL] [Abstract][Full Text] [Related]
11. Intravitreal Recombinant Tissue Plasminogen Activator and Sulphur Hexafluoride Gas for Submacular Haemorrhage Displacement in Age-Related Macular Degeneration: Looking behind the Blood.
Maggio E; Peroglio Deiro A; Mete M; Sartore M; Polito A; Prigione G; Guerriero M; Pertile G
Ophthalmologica; 2020; 243(3):224-235. PubMed ID: 31905361
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors for visual acuity improvement after treatment of submacular hemorrhage secondary to exudative age-related macular degeneration.
Barayev E; Tiosano A; Zlatkin R; Elul R; Dotan A; Hadayer A; Gal-Or O; Ehrlich R
Eur J Ophthalmol; 2024 May; 34(3):825-833. PubMed ID: 37715632
[TBL] [Abstract][Full Text] [Related]
13. Intravitreal Tissue Plasminogen Activator, Ranibizumab, and Gas Injection for Submacular Hemorrhage in Polypoidal Choroidal Vasculopathy.
Kitagawa Y; Shimada H; Mori R; Tanaka K; Yuzawa M
Ophthalmology; 2016 Jun; 123(6):1278-86. PubMed ID: 26949121
[TBL] [Abstract][Full Text] [Related]
14. INTRAVITREAL VERSUS SUBRETINAL ADMINISTRATION OF RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR COMBINED WITH GAS FOR ACUTE SUBMACULAR HEMORRHAGES DUE TO AGE-RELATED MACULAR DEGENERATION: An Exploratory Prospective Study.
de Jong JH; van Zeeburg EJ; Cereda MG; van Velthoven ME; Faridpooya K; Vermeer KA; van Meurs JC
Retina; 2016 May; 36(5):914-25. PubMed ID: 26807631
[TBL] [Abstract][Full Text] [Related]
15. Clinical Outcomes of Eyes with Submacular Hemorrhage Secondary to Age-related Macular Degeneration Treated with Anti-vascular Endothelial Growth Factor.
Kim KH; Kim JH; Chang YS; Lee TG; Kim JW; Lew YJ
Korean J Ophthalmol; 2015 Oct; 29(5):315-24. PubMed ID: 26457037
[TBL] [Abstract][Full Text] [Related]
16. Intravitreal anti-VEGF monotherapy for thick submacular hemorrhage of less than 1 week duration secondary to neovascular age-related macular degeneration.
Jain S; Kishore K; Sharma YR
Indian J Ophthalmol; 2013 Sep; 61(9):490-6. PubMed ID: 24104707
[TBL] [Abstract][Full Text] [Related]
17. Comparison of subretinal versus intravitreal injection of recombinant tissue plasminogen activator with gas for submacular hemorrhage secondary to wet age-related macular degeneration: treatment outcomes and brief literature review.
Tranos P; Tsiropoulos GN; Koronis S; Vakalis A; Asteriadis S; Stavrakas P
Int Ophthalmol; 2021 Dec; 41(12):4037-4046. PubMed ID: 34331185
[TBL] [Abstract][Full Text] [Related]
18. Flattening of retinal pigment epithelial detachments after pneumatic displacement of submacular hemorrhages secondary to age-related macular degeneration.
Kimura M; Yasukawa T; Shibata Y; Kato A; Hirano Y; Uemura A; Yoshida M; Ogura Y
Graefes Arch Clin Exp Ophthalmol; 2018 Oct; 256(10):1823-1829. PubMed ID: 29961921
[TBL] [Abstract][Full Text] [Related]
19. Intravitreal anti-vascular endothelial growth factor monotherapy for large submacular hemorrhage secondary to neovascular age-related macular degeneration.
Kim HS; Cho HJ; Yoo SG; Kim JH; Han JI; Lee TG; Kim JW
Eye (Lond); 2015 Sep; 29(9):1141-51. PubMed ID: 26272443
[TBL] [Abstract][Full Text] [Related]
20. Progression of macular atrophy in patients undergoing anti-vascular endothelial growth factor therapy for neovascular age-related macular degeneration.
Cho HJ; Park SM; Kim J; Nah SK; Lee J; Lee DW; Kim JW
Acta Ophthalmol; 2021 Jun; 99(4):e540-e546. PubMed ID: 32996674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
